Table 1 COVID-19 testing status by sociodemographic characteristics, risk category and risk criteria.
From: Comparison of COVID-19 outcomes among shielded and non-shielded populations
COVID-19 testing status | p value | ||
---|---|---|---|
Not tested | Tested | ||
N = 1,299,206 | N = 15,865 | ||
n (%) | n (%) | ||
Age group (years) | < 0.0001 | ||
0–24 | 355,238 (99.49) | 1822 (0.51) | |
25–44 | 410,408 (99.22) | 3247 (0.78) | |
45–64 | 340,268 (98.65) | 4660 (1.35) | |
≥ 65 | 193,292 (96.92) | 6136 (3.08) | |
Sex | < 0.0001 | ||
Male | 654,041 (99.01) | 6569 (0.99) | |
Female | 645,165 (98.58) | 9296 (1.42) | |
Deprivation quintile | < 0.0001 | ||
1 (most deprived) | 461,672 (98.67) | 6211 (1.33) | |
2 | 230,402 (98.75) | 2921 (1.25) | |
3 | 194,702 (98.90) | 2175 (1.10) | |
4 | 173,456 (98.93) | 1883 (1.07) | |
5 (most affluent) | 238,974 (98.89) | 2675 (1.11) | |
Risk category | < 0.0001 | ||
Low | 928,420 (99.27) | 6819 (0.73) | |
Moderate | 345,913 (97.97) | 7172 (2.03) | |
Shielded | 24,873 (92.99) | 1874 (7.01) | |
Moderate risk criteria | |||
Chronic respiratory disease | 149,325 (98.33) | 2540 (1.67) | < 0.0001 |
Heart disease | 46,728 (96.21) | 1843 (3.79) | < 0.0001 |
Hypertension | 156,286 (97.55) | 3929 (2.45) | < 0.0001 |
Diabetes | 62,482 (97.09) | 1876 (2.91) | < 0.0001 |
Weakened immune system | 1140 (95.40) | 55 (4.60) | < 0.0001 |
≥ 70 years of age | 134,305 (96.23) | 5263 (3.77) | < 0.0001 |
Shielded criteria | |||
Severe respiratory disease | 17,146 (94.48) | 1001 (5.52) | < 0.0001 |
Specific cancers | 2075 (83.30) | 416 (16.70) | < 0.0001 |
Pregnant with severe heart disease | < 5 | 0 | – |
Immunosuppressive therapy | 5028 (94.00) | 321 (6.00) | < 0.0001 |
Solid organ transplant | 1149 (92.29) | 96 (7.71) | < 0.0001 |
Rare diseases and inborn errors of metabolism | 1623 (91.95) | 142 (8.05) | < 0.0001 |
Renal dialysis | 305 (64.21) | 170 (35.79) | < 0.0001 |